Selected biomarkers of depression: what are the effects of cytokines and inflammation
Open accessThe DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index; 27 of the 178 sources its claims cite were checked for support.
Abstract
Depression is one of the leading mental illnesses worldwide and lowers the quality of life of many. According to WHO, about 5% of the worldwide population suffers from depression. Newer studies report a staggering global prevalence of 27.6%, and it is rising. Professionally, depression belonging to affective disorders is a psychiatric illness, and the category of major depressive disorder (MDD) comprises various diagnoses related to persistent and disruptive mood disorders. Due to this fact, it is imperative to find a way to assess depression quantitatively using a specific biomarker or a panel of biomarkers that would be able to reflect the patients’ state and the effects of therapy. Cytokines, hormones, oxidative stress markers, and neuropeptides are studied in association with depression. The latest research into inflammatory cytokines shows that their relationship with the etiology of depression is causative. There are stronger cytokine reactions to pathogens and stressors in depression. If combined with other predisposing factors, responses lead to prolonged inflammatory processes, prolonged dysregulation of various axes, stress, pain, mood changes, anxiety, and depression. This review focuses on the most recent data on cytokines as markers of depression concerning their roles in its pathogenesis, their possible use in diagnosis and management, their different levels in bodily fluids, and their similarities in animal studies. However, cytokines are not isolated from the pathophysiologic mechanisms of depression or other psychiatric disorders. Their effects are only a part of the whole pathway.
Overview
CoChat Summary
TL;DR
This narrative review summarizes evidence that inflammatory cytokines such as IL-1β, IL-6, IL-12, IL-18, IFN-γ, and TNF are altered in depression and may serve as biomarkers for diagnosis, severity, and treatment response. It concludes that cytokines are viable research targets, but findings are inconsistent and causality remains unclear.
Key findings
- Cytokines including IL-1β, IL-6, IL-12, IL-18, IFN-γ, and TNF-α are repeatedly associated with depression; the review concludes they are viable options for quantitative depression research, preferably using non-invasively collected bodily fluids.
- Meta-analytic evidence cited includes elevated IL-3 in depression (107 studies, 5,166 patients and 5,083 controls), elevated IL-12 in an 82-study meta-analysis, and a mean sIL-2R difference of 0.555 U/mL between healthy subjects and MDD patients.
- Some markers relate to treatment: elevated baseline TNF was associated with worse antidepressant outcomes; IL-17A was elevated in MDD non-responders; IL-13 showed a 69% reduction at week 52 of SSRI treatment; multi-assay panels including sTNFR2 achieved 69.2% correct classification (62.5% sensitivity, 82.5% specificity) and, in another panel, 91.1% sensitivity and 81.3% specificity for MDD.
- Findings are often contradictory: IL-1β, IL-6, IL-8, IL-10, CCL2, CCL5, and TNF show conflicting elevations or decreases across studies, with unclear relationships between peripheral and CSF levels and between animal and human results.
Methods
- Narrative review of recent data on cytokines as markers of depression, covering their roles in pathogenesis, diagnosis, management, bodily fluid levels, and similarities in animal studies.
- The paper synthesizes human clinical studies, meta-analyses, systematic reviews, and animal models, organized cytokine by cytokine.
- No systematic search strategy, inclusion criteria, or quality assessment is stated in the paper.
Limitations
- The paper states that cytokines are not isolated from the pathophysiologic mechanisms of depression or other psychiatric disorders and that their effects are only part of the whole pathway.
- The paper repeatedly notes inconsistent findings, unclear cause-versus-consequence relationships, and differences between peripheral and central levels or between animal models and human patients.
- Evident from the text: as a narrative review without a described systematic search or quality appraisal, it may be subject to selection and interpretation bias, and many cited studies are small or heterogeneous.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
22 Valid · 0 Not valid · 113 Not checked · 23 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A meta-analysis concluded that IL-1β was significantly elevated in patients with depression and Alzheimer’s disease (AD), while IL-6 was elevated only in patients with depression [38].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.1. Interleukin-1 Beta
What the sources say
- Partly supportedcites [38] Ng, 2018, IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer’s Disease: Systematic Review and Meta-Analysis, Sci. Rep. sourceExperimental — accuracy not yet measured
The Results (Meta-Analysis for Elderly with and without Alzheimer’s disease) report significantly higher peripheral IL-1β in elderly patients with Alzheimer’s disease than in controls (p = 0.041). The Discussion qualifies this as significant before Bonferroni adjustment, and the Conclusion says that after correction for multiple testing, only IL-6 in elderly patients with depression remained significantly elevated. The citing sentence omits that qualification. (LLM, conf=0.90)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“P2X7 inhibition has been associated with antidepressant-like effects, and IL-1β knockout mice failed to express these receptors [48,49].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.1. Interleukin-1 Beta
What the sources say
- Not checked yetcites [48] Seil, 2012, Distinct Regulation by Lipopolysaccharides of the Expression of Interleukin-1β by Murine Macrophages and Salivary Glands, Innate Immun. source
- Could not verifycites [49] Clark, 2010, P2X7-Dependent Release of Interleukin-1 and Nociception in the Spinal Cord Following Lipopolysaccharide, J. Neurosci. sourceExperimental — accuracy not yet measured
The Results section on LPS-induced mechanical hypersensitivity reports that P2X7 antagonists prevented hyperalgesia, not that they had antidepressant-like effects. A search for depression and antidepressant-like behavior found no passage addressing that outcome in our copy; page numbers were unavailable. (LLM, conf=0.75)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Elomaa et al. described elevated IL-5 levels in 58 patients with MDD, though a later meta-analysis did find changes in levels of IL-5 to be inconclusive in depressed patients.”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.5. Interleukin-5
What the sources say
- Supportedcites [35] Freitas, 2017, Peripheral Cytokine and Chemokine Alterations in Depression: A Meta-Analysis of 82 Studies, Acta Psychiatr. Scand. source
The 'Other mediators' section of our copy lists IL-5 among mediators measured in at least three studies and states that levels 'did not significantly differ between individuals with MDD and HCs'. Table 1 gives the IL-5 primary meta-analysis as 4 studies (198 MDD vs 322 controls), Hedge's g = 0.396 (95% CI -0.072 to 0.865), P = 0.097, I² = 82.1% — a non-significant, borderline estimate with large heterogeneity, i.e. no established IL-5 change in depression. The citing paraphrase renders the paper's null/borderline result as 'inconclusive', which is a fair (if slightly hedged) restatement of what this 2017 meta-analysis reports for IL-5 in MDD patients. (LLM, conf=0.86)
- Not checked yetcites [77] Ho, 2021, Circulating Cytokines as Predictors of Depression in Patients with Breast Cancer, J. Psychiatr. Res. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Female rats with lower IL-8 levels are more susceptible to medication and electroconvulsive therapy (ECT) [92,93].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.7. Interleukin-8
What the sources say
- Partly supportedcites [92] Kruse, 2021, Depression Treatment Response to Ketamine: Sex-Specific Role of Interleukin-8, but Not Other Inflammatory Markers, Transl. Psychiatry sourceExperimental — accuracy not yet measured
The Introduction and Discussion report that lower baseline IL-8 was associated with better ECT response in female patients. The Discussion also reports an association with antidepressant-medication response, but says sex differences were not evaluated in those studies. These findings concern people, not female rats. (LLM, conf=0.90)
- Partly supportedcites [93] Kruse, 2020, Inflammation and Depression Treatment Response to Electroconvulsive Therapy: Sex-Specific Role of Interleukin-8, Brain Behav. Immun. sourceExperimental — accuracy not yet measured
The Discussion reports that lower baseline IL-8 was associated with improvement after ECT in female patients, not female rats. It also reports lower baseline IL-8 among antidepressant-medication responders in a meta-analysis, but says that analysis did not evaluate sex. Thus neither the rat population nor a female-specific medication response is supported. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“IL-4-driven Arg1+ microglia in the hippocampus trigger brain-derived neurotrophic factor (BDNF)-driven neurogenesis in reaction to stress, resulting in improved resilience to stress-induced depression.”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.4. Interleukin-4
What the sources say
- Supportedcites [69] Zhang, 2021, IL4-Driven Microglia Modulate Stress Resilience through BDNF-Dependent Neurogenesis, Sci. Adv. source
The Discussion states that IL4-driven Arg1+ microglia ameliorate chronic stress–induced depressive-like behaviors in mice through BDNF-dependent hippocampal neurogenesis. The Results section on stress-induced depressive-like behaviors also reports that blocking BDNF signaling or neurogenesis abolished the protective effect. (LLM, conf=0.93)
- Not checked yetcites [70] Wachholz, 2017, Interleukin-4 Is a Participant in the Regulation of Depressive-like Behavior, Behav. Brain Res. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
105 more claims · 13 with their cited sources checked
Create a free account to see all 158 claims and to verify the 151 references still open.
- It may state two separate claims as one. 38
- Probably not a substantial claim. 11
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar associations have been reported with cytokines and neuropeptides in depression (13).”
From Retrospective evaluation of novel serum inflammatory biomarkers in first-episode psychiatric disorders: diagnostic potential and immune dysregulation (2024) · doi:10.3389/fpsyt.2024.1442954 · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.11. Interleukin-13
“The above-cited meta-analysis by Köhler et al. underpins the association between peripheral IL-13 elevation and MDD [14].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > References
“14. Siwek M. Sowa-Kućma M. Dudek D. Styczeń K. Szewczyk B. Kotarska K. Misztak P. Pilc A. Wolak M. Nowak G. Oxidative Stress Markers in Affective Disorders”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.1. Interleukin-1 Beta
“The use of intrahippocampal IL-1RA causes downregulation of brain-derived neurotrophic factor (BDNF) in individuals experiencing social isolation [52].”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > References
“Brain-Derived Neurotrophic Factor MRNA Downregulation Produced by Social Isolation Is Blocked by Intrahippocampal Interleukin-1 Receptor Antagonist”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.19. Tumor Necrosis Factor
“namely c.-1211T > C—TNF-α (rs1799964)”
§ Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? > 2. Cytokines > 2.19. Tumor Necrosis Factor
“the C allele in the C/T genotype of rs179964 was associated with positive treatment outcomes and low serum levels of TNF.”
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475 · cited 1×
“Cytokines, hormones, oxidative stress markers, and neuropeptides have been studied in association with depression [8].”
BackgroundSantomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02143-7 · Cited by 5,444 · cited 1×
“6%, and while the prevalence is rising globally, the late SARS-CoV-2 pandemic caused problems, especially in middle- and low-income countries [3,4].”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“Levels of cytokines have been found significantly altered in depression, and patients, even if otherwise clinically healthy, show elevated or decreased levels of various cytokines and their soluble receptors in bodily fluids [18].”
BackgroundThe regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
Biological basis of the behavior of sick animals
Hart, B. L. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80004-6 · Cited by 2,223 · cited 1×
“This cytokine was first implicated in the etiology of sickness behavior and later linked to depressive disorder along with IL-6 and TNF [36,37].”
BackgroundPeripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.001 · Cited by 1,129 · cited 1×
“The link between both acute and chronic inflammation is connected to depression, as the relationship between proinflammatory cytokines and depression has been studied for a long time [17].”
BackgroundNeuroinflammation and depression: A review
Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107 · cited 1×
“, depletion of brain serotonin or the effects of inflammation and the immune system response, are observed in depression [9,10].”
BackgroundInflammasome activation and regulation: toward a better understanding of complex mechanisms
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Discovery · doi:10.1038/s41421-020-0167-x · Cited by 1,026
Liu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
Osimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., & Howes, O. D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.02.010 · Cited by 937 · cited 1×
“analyzed 107 studies comprising 5166 patients and 5083 controls and found IL-3 among those cytokines whose blood levels were significantly elevated in depressed subjects [65].”
Backgroundlnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses
Minty, A., Chalon, P., Derocq, J.-M., Dumont, X., Guillemot, J.-C., Kaghad, M., Labit, C., Leplatois, P., Liauzun, P., Miloux, B., et al. (1993) · Nature · doi:10.1038/362248a0 · Cited by 871
Inflammation: Depression Fans the Flames and Feasts on the Heat
Kiecolt-Glaser, J. K., Derry, H. M., & Fagundes, C. P. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020152 · Cited by 844
Kola, L., Kohrt, B. A., Hanlon, C., Naslund, J. A., Sikander, S., Balaji, M., Benjet, C., Cheung, E. Y. L., Eaton, J., Gonsalves, P., et al. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00025-0 · Cited by 835 · cited 1×
“6%, and while the prevalence is rising globally, the late SARS-CoV-2 pandemic caused problems, especially in middle- and low-income countries [3,4].”
BackgroundRouvier, E., Luciani, M. F., Mattéi, M. G., Denizot, F., & Golstein, P. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5445 · Cited by 775
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
Matusevicius, D., Kivisäkk, P., He, B., Kostulas, N., Özenci, V, Fredrikson, S., & Link, H. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500206 · Cited by 751
Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622 · cited 1×
“Contrary to these findings, sIL-6R was decreased in the CSF of elderly depressed patients medicated with antidepressants in combination with neuroleptics or benzodiazepines [89].”
ResultPathogenesis of depression: Insights from human and rodent studies
Ménard, C., Hodes, G. E., & Russo, S. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.053 · Cited by 593
Ng, A., Tam, W. W., Zhang, M. W., Ho, C. S., Husain, S. F., McIntyre, R. S., & Ho, R. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-30487-6 · Cited by 572 · cited 2×
“A meta-analysis concluded that IL-1β was significantly elevated in patients with depression and Alzheimer’s disease (AD), while IL-6 was elevated only in patients with depression [38].”
BackgroundInflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
Wong, M.-L., Inserra, A., Lewis, M. D., Mastronardi, C. A., Leong, L., Choo, J., Kentish, S., Xie, P., Morrison, M., Wesselingh, S. L., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.46 · Cited by 568
Shelton, R. C., Claiborne, J., Sidoryk-Wegrzynowicz, M., Reddy, R., Aschner, M., Lewis, D. A., & Mirnics, K. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.52 · Cited by 511
Witek-Janusek, L., Albuquerque, K., Chroniak, K. R., Chroniak, C., Durazo-Arvizu, R., & Mathews, H. L. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.01.012 · Cited by 506
Exposure to Acute Stress Induces Brain Interleukin-1β Protein in the Rat
Nguyen, K. T., Deak, T., Owens, S. M., Kohno, T., Fleshner, M., Watkins, L. R., & Maier, S. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02239.1998 · Cited by 460 · cited 1×
“This raises the question of whether this occurrence is more related to depression or acute reaction to stress, as mice under stress expressed more IL-1β than controls [42,43].”
BackgroundAlcocer-Gómez, E., de Miguel, M., Casas-Barquero, N., Núñez-Vasco, J., Sánchez-Alcazar, J. A., Fernández-Rodríguez, A., & Cordero, M. D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.10.017 · Cited by 443
Liu, J. J., Wei, Y. B., Strawbridge, R., Bao, Y., Chang, S., Shi, L., Que, J., Gadad, B. S., Trivedi, M. H., Kelsoe, J. R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0474-5 · Cited by 429 · cited 2×
“There was no difference in IL-12 (plus ten other cytokines) levels between subsequent responders and non-responders [16].”
BackgroundA Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder
Young, J. J., Bruno, D., & Pomara, N. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.07.032 · Cited by 422 · cited 1×
“At the same time, overexpression of IL-6 led to a reduction in these behaviors [83,84].”
BackgroundPsychological, behavioral, and immune changes after a psychological intervention: a clinical trial
Andersen, B. L., Farrar, W. B., Golden-Kreutz, D. M., Glaser, R., Emery, C. F., Crespin, T. R., Shapiro, C. L., & Carson, W. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.030 · Cited by 416
Stress and Immune Responses After Surgical Treatment for Regional Breast Cancer
Andersen, B. L., Farrar, W. B., Golden-Kreutz, D., Kutz, L. A., MacCallum, R., Courtney, M. E., & Glaser, R. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.1.30 · Cited by 398
Licinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380
Interleukin‐6: Structure‐function relationships
Simpson, R. J., Hammacher, A., Smith, D. K., Matthews, J. M., & Ward, L. D. (1997) · Protein Science · doi:10.1002/pro.5560060501 · Cited by 371
Maes, M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00088-8 · Cited by 357
Cerebrospinal Cytokine Levels in Patients with Acute Depression
Levine, J., Barak, Y., Chengappa, K. N. R., Rapoport, A., Rebey, M., & Barak, V. (1999) · Neuropsychobiology · doi:10.1159/000026615 · Cited by 354 · cited 1×
“This raises the question of whether this occurrence is more related to depression or acute reaction to stress, as mice under stress expressed more IL-1β than controls [42,43].”
BackgroundTumor necrosis factor-α converting enzyme
Black, R. A. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00097-8 · Cited by 346
Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder
Hoge, E. A., Brandstetter, K., Moshier, S., Pollack, M. H., Wong, K. K., & Simon, N. M. (2009) · Depression and Anxiety · doi:10.1002/da.20564 · Cited by 343
Immune suppression and immune activation in depression
Blume, J., Douglas, S. D., & Evans, D. L. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.008 · Cited by 338 · cited 1×
“There is a disparity in immune suppression and activation in depression; this is a cycle of cause/effect and leads to impaired cellular immunity and inflammation [19].”
BackgroundMajor Depressive Disorder: Advances in Neuroscience Research and Translational Applications
Li, Z., Ruan, M., Chen, J., & Fang, Y. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00638-3 · Cited by 326
Effects of Cytokines on Cerebral Neurotransmission: Comparison with the Effects of Stress
Dunn, A. J., Wang, J., & Ando, T. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_8 · Cited by 316
Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., et al. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/76396 · Cited by 315
Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
Iwaszko, M., Biały, S., & Bogunia-Kubik, K. (2021) · Cells · doi:10.3390/cells10113000 · Cited by 311
Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders
Müller, N., & Ackenheil, M. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00179-6 · Cited by 306
The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder
Maes, M., & Carvalho, A. F. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1016-x · Cited by 306 · cited 1×
“These findings complement the theory of two opposite, counterregulating systems: the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) [20].”
BackgroundMaes, M., Scharpé, S., Meltzer, H. Y., Okayli, G., Bosmans, E., D'Hondt, P., Vanden Bossche, B., & Cosyns, P. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90003-5 · Cited by 302
Endotoxin-induced serum factor that stimulates gamma interferon production
Nakamura, K., Okamura, H., Wada, M., Nagata, K., & Tamura, T. (1989) · Infection and Immunity · doi:10.1128/iai.57.2.590-595.1989 · Cited by 299
Psychological Treatment of Depression in Primary Care: Recent Developments
Cuijpers, P., Quero, S., Dowrick, C., & Arroll, B. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1117-x · Cited by 296
Wong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295
Clark, A. K., Staniland, A. A., Marchand, F., Kaan, T. K. Y., McMahon, S. B., & Malcangio, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3295-09.2010 · Cited by 291 · cited 1×
“Noteworthy, however, is the relation between IL-1β and the P2X family of receptors, in which P2X7 inhibition has been associated with antidepressant-like effects, and IL-1β knockout mice failed to express these receptors [48,49].”
BackgroundIncrease in Interleukin-1β in Late-Life Depression
Thomas, A. J., Davis, S., Morris, C., Jackson, E., Harrison, R., & O’Brien, J. T. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.175 · Cited by 291 · cited 1×
“, who found that elderly subjects (above 60 years) expressed IL-1β proportionally to illness severity [44].”
BackgroundLeighton, S. P., Nerurkar, L., Krishnadas, R., Johnman, C., Graham, G. J., & Cavanagh, J. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.205 · Cited by 291
IL4-driven microglia modulate stress resilience through BDNF-dependent neurogenesis
Zhang, J., Rong, P., Zhang, L., He, H., Zhou, T., Fan, Y., Mo, L., Zhao, Q., Han, Y., Li, S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abb9888 · Cited by 287 · cited 1×
“The results showed overexpression of IL-4 in the mice group with low-stress susceptibility [69,70].”
BackgroundA detailed examination of cytokine abnormalities in Major Depressive Disorder
Simon, N. M., McNamara, K., Chow, C. W., Maser, R. S., Papakostas, G. I., Pollack, M. H., Nierenberg, A. A., Fava, M., & Wong, K. K. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.004 · Cited by 286
Integrating Interleukin-6 into depression diagnosis and treatment
Hodes, G. E., Ménard, C., & Russo, S. J. (2016) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.03.003 · Cited by 271
Maes, M., Bosmans, E., Suy, E., Vandervorst, C., DeJonckheere, C., & Raus, J. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb03163.x · Cited by 268 · cited 1×
“The role sIL-2R may play in depression was first mentioned in the literature in 1991 in an article exploring depression-related disturbances in mitogen-induced lymphocyte responses together with the production of IL-1β and sIL-2R, suggesting that T cell activation may be one of the characteristics of MDD [58].”
BackgroundMiller, A. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.006 · Cited by 261 · cited 1×
“Cytokines have been heavily discussed in stress, anxiety, and depression [23].”
BackgroundElevated Cytokine Expression in the Orbitofrontal Cortex of Victims of Suicide
Tonelli, L. H., Stiller, J., Rujescu, D., Giegling, I., Schneider, B., Maurer, K., Schnabel, A., Möller, H. ‐., Chen, H. H., & Postolache, T. T. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01128.x · Cited by 252
The IL-2 – IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor
Damoiseaux, J. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108515 · Cited by 252 · cited 1×
“sIL-2R has a low affinity for IL-2 and can function either as a decoy receptor reducing the bio-availability of IL-2 or by enabling trans presentation to cells expressing the dimeric, intermediate-affinity IL-2R, which leads to enhanced or suppressed immune response depending on the type of cells involved [56,57].”
BackgroundBarrientos, R. M., Sprunger, D. B., Campeau, S., Higgins, E. A., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00564-5 · Cited by 251 · cited 1×
“The use of intrahippocampal IL-1RA causes downregulation of brain-derived neurotrophic factor (BDNF) in individuals experiencing social isolation [52].”
BackgroundModulation of murine macrophage function by IL-13
Doherty, T. M., Kastelein, R., Menon, S., Andrade, S., & Coffman, R. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.12.7151 · Cited by 249
IL-18: a key player in neuroinflammation and neurodegeneration?
Felderhoff-Mueser, U., Schmidt, O. I., Oberholzer, A., Bührer, C., & Stahel, P. F. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.06.008 · Cited by 242
Brebner, K. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00166-9 · Cited by 241 · cited 1×
“This cytokine was first implicated in the etiology of sickness behavior and later linked to depressive disorder along with IL-6 and TNF [36,37].”
BackgroundKim, Y.-K., Suh, I.-B., Kim, H., Han, C.-S., Lim, C.-S., Choi, S.-H., & Licinio, J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001084 · Cited by 224
Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases
Bose, S., & Cho, J. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0161-z · Cited by 220
Exosomes, DAMPs and miRNA: Features of Stress Physiology and Immune Homeostasis
Fleshner, M., & Crane, C. R. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.08.002 · Cited by 212 · cited 10×
“First introduced as TNF due to its capability of inducing necrosis in various neoplasms in mice, it was later renamed TNF-α because a previously described factor known as lymphotoxin was found to be homologous to TNF.”
BackgroundInfluentialNLRP1 inflammasome contributes to chronic stress-induced depressive-like behaviors in mice
Song, A.-Q., Gao, B., Fan, J.-J., Zhu, Y.-J., Zhou, J., Wang, Y.-L., Xu, L.-Z., & Wu, W.-N. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01848-8 · Cited by 204
Role of Interleukin-13 in Asthma
Corren, J. (2013) · Current Allergy and Asthma Reports · doi:10.1007/s11882-013-0373-9 · Cited by 200
Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism
Singh, V. K. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00014-8 · Cited by 199
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197 · cited 1×
“These markers can be obtained from serum, saliva, cerebrospinal fluid (CSF), urine, feces, or hair, using a noninvasive liquid biopsy [7].”
MethodLiu, J., Cao, S., Kim, S., Chung, E., Homma, Y., Guan, X., Jimenez, V., & Ma, X. (2005) · Current Immunology Reviews · doi:10.2174/1573395054065115 · Cited by 189
Th2 Cytokine Response in Major Depressive Disorder Patients before Treatment
Pavón, L., Sandoval-López, G., Eugenia Hernández, M., Loría, F., Estrada, I., Pérez, M., Moreno, J., Ávila, U., Leff, P., Antón, B., et al. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.08.014 · Cited by 187
Beurel, E., & Lowell, J. A. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.08.001 · Cited by 187 · cited 1×
“T helper 17 cells (Th17) with IL-17A are studied in association with neuroinflammation [31].”
BackgroundPerry, B. I., Upthegrove, R., Kappelmann, N., Jones, P. B., Burgess, S., & Khandaker, G. M. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.07.009 · Cited by 187
Inflammatory cytokine-associated depression
Lotrich, F. E. (2015) · Brain Research · doi:10.1016/j.brainres.2014.06.032 · Cited by 183 · cited 1×
“receptors, and ligands have been studied in association with mood worsening, depression risk, and depression [30].”
BackgroundPapakostas, G. I., Shelton, R. C., Kinrys, G., Henry, M. E., Bakow, B. R., Lipkin, S. H., Pi, B., Thurmond, L., & Bilello, J. A. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.166 · Cited by 180
Cytokines and depression: fortuitous or causative association?
Dantzer, R., Wollman, E., Vitkovic, L., & Yirmiya, R. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000572 · Cited by 174
Zhang, J., He, H., Qiao, Y., Zhou, T., He, H., Yi, S., Zhang, L., Mo, L., Li, Y., Jiang, W., et al. (2020) · Glia · doi:10.1002/glia.23878 · Cited by 174
Caraci, F., Spampinato, S. F., Morgese, M. G., Tascedda, F., Salluzzo, M. G., Giambirtone, M. C., Caruso, G., Munafò, A., Torrisi, S. A., Leggio, G. M., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.007 · Cited by 172
Zhang, H.-Y., Wang, Y., He, Y., Wang, T., Huang, X.-H., Zhao, C.-M., Zhang, L., Li, S.-W., Wang, C., Qu, Y.-N., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01871-9 · Cited by 161
Nowak, W., Grendas, L. N., Sanmarco, L. M., Estecho, I. G., Arena, Á. R., Eberhardt, N., Rodante, D. E., Aoki, M. P., Daray, F. M., Carrera Silva, E. A., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.063 · Cited by 159
Role of inflammatory cytokines in depression: Focus on interleukin-1β
Farooq, R. K., Asghar, K., Kanwal, S., & Zulqernain, A. (2017) · Biomedical Reports · doi:10.3892/br.2016.807 · Cited by 153 · cited 1×
“However, their peripheral levels are also studied in association with antidepressant treatment [15,16].”
BackgroundAl-Hakeim, H. K., Al-Rammahi, D. A., & Al-Dujaili, A. H. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.044 · Cited by 152
The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
Lee, K.-M., & Kim, Y.-K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.015 · Cited by 150
The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory
Marciniak, E., Faivre, E., Dutar, P., Alves Pires, C., Demeyer, D., Caillierez, R., Laloux, C., Buée, L., Blum, D., & Humez, S. (2015) · Scientific Reports · doi:10.1038/srep15862 · Cited by 148
Das, R. K., Emon, M. P. Z., Shahriar, M., Nahar, Z., Islam, S. M. A., Bhuiyan, M. A., Islam, S. N., & Islam, M. R. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113568 · Cited by 147
Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity
Schmidt, F. M., Lichtblau, N., Minkwitz, J., Chittka, T., Thormann, J., Kirkby, K. C., Sander, C., Mergl, R., Faßhauer, M., Stumvoll, M., et al. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.04.021 · Cited by 146
Byrne, M. L., O’Brien-Simpson, N. M., Reynolds, E. C., Walsh, K. A., Laughton, K., Waloszek, J. M., Woods, M. J., Trinder, J., & Allen, N. B. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.08.010 · Cited by 144
Oxidative stress markers in affective disorders
Siwek, M., Sowa-Kućma, M., Dudek, D., Styczeń, K., Szewczyk, B., Kotarska, K., Misztak, P., Pilc, A., Wolak, M., & Nowak, G. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71517-2 · Cited by 142 · cited 2×
“, vitamin E, zinc, glutathione, or coenzyme Q10) are the markers, and their impaired status can be corrected by a successful therapy [14].”
BackgroundHernández, M. E., Mendieta, D., Martínez-Fong, D., Loría, F., Moreno, J., Estrada, I., Bojalil, R., & Pavón, L. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.08.001 · Cited by 140
Neuroendocrine Regulation of Brain Cytokines After Psychological Stress
Johnson, J. D., Barnard, D. F., Kulp, A. C., & Mehta, D. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00053 · Cited by 135 · cited 10×
“First introduced as TNF due to its capability of inducing necrosis in various neoplasms in mice, it was later renamed TNF-α because a previously described factor known as lymphotoxin was found to be homologous to TNF.”
BackgroundInfluentialVogelzangs, N., Beekman, A. T., van Reedt Dortland, A. K., Schoevers, R. A., Giltay, E. J., de Jonge, P., & Penninx, B. W. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.9 · Cited by 133
Kolosowska, N., Keuters, M. H., Wojciechowski, S., Keksa-Goldsteine, V., Laine, M., Malm, T., Goldsteins, G., Koistinaho, J., & Dhungana, H. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00761-0 · Cited by 133
Peluso, I. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i35.5606 · Cited by 130
Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders
Teixeira, A. L., Gama, C. S., Rocha, N. P., & Teixeira, M. M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00241 · Cited by 129
Treatment-Resistant Depression: Approaches to Treatment
Kverno, K. S., & Mangano, E. (2021) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20210816-01 · Cited by 121 · cited 1×
“New treatment targets, be they psychological or pharmaceutic, are constantly being developed, as depression can often be therapy-resistant [12,13].”
BackgroundAtopy and depression: results from the Northern Finland 1966 Birth Cohort Study
Timonen, M., Jokelainen, J. J., Hakko, H. H., Silvennoinen‐Kassinen, S., Meyer‐Rochow, V. B., Herva, A., & Räsänen, P. K. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001274 · Cited by 119
Depression and Interleukin-6 Signaling: A Mendelian Randomization Study
Kelly, K. M., Smith, J. A., & Mezuk, B. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.02.019 · Cited by 117 · cited 1×
“In addition to increased IL-6 levels, sIL-R6 levels were reported in depressed patients, with elevated levels of both persisting even after the start of antidepressant treatment [87,88].”
BackgroundRole of interleukin 8 in depression and other psychiatric disorders
Tsai, S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110173 · Cited by 116 · cited 1×
“At the same time, its connection to MDD is relatively new and inconsistent [90].”
BackgroundCorwin, E. J., Johnston, N., & Pugh, L. (2008) · Biological Research For Nursing · doi:10.1177/1099800408323220 · Cited by 111 · cited 3×
“reported elevated IL-1β levels in women suffering from postpartum depression (PPD) [45].”
BackgroundInfluentialMedina-Rodriguez, E. M., Madorma, D., O’Connor, G., Mason, B. L., Han, D., Deo, S. K., Oppenheimer, M., Nemeroff, C. B., Trivedi, M. H., Daunert, S., et al. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.19090960 · Cited by 110
Kubera, M., Maes, M., Holan, V., Basta-Kaim, A., Roman, A., & Shani, J. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00182-8 · Cited by 103
Tsai, S.-J. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.06.001 · Cited by 98
Chakraborty, S., Kubatzky, K. F., & Mitra, D. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092113 · Cited by 98 · cited 1×
“The binding of IL-9 with its receptor promotes cross phosphorylation of Janus kinase (JAK) 1 and JAK3, leading to the activation of signal transducer and activator of transcription (STAT) 1, 3, and 5 [99,100].”
BackgroundEffects of SSRIs on Peripheral Inflammatory Cytokines in Patients with Generalized Anxiety Disorder
Hou, R., Ye, G., Liu, Y., Chen, X., Pan, M., Zhu, F., Fu, J., Fu, T., Liu, Q., Gao, Z., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.001 · Cited by 97
Sanada, K., Montero-Marin, J., Barceló-Soler, A., Ikuse, D., Ota, M., Hirata, A., Yoshizawa, A., Hatanaka, R., Valero, M. S., Demarzo, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072484 · Cited by 96
Kern, S., Skoog, I., Börjesson-Hanson, A., Blennow, K., Zetterberg, H., Östling, S., Kern, J., Gudmundsson, P., Marlow, T., Rosengren, L., et al. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.05.006 · Cited by 94 · cited 1×
“However, inconsistencies continue, as in a study on geriatric depression (patients 70–84 years of age), higher levels of IL-8 and IL-6 in CSF were associated with current depression [95].”
BackgroundIncreased soluble tumor necrosis factor‐α receptors in patients with major depressive disorder
Grassi‐Oliveira, R., Brietzke, E., Pezzi, J. C., Lopes, R. P., Teixeira, A. L., & Bauer, M. E. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01918.x · Cited by 92
Peripheral Chemokine Levels in Women with Recurrent Major Depression with Suicidal Ideation
Grassi-Oliveira, R., Brieztke, E., Teixeira, A., Pezzi, J. C., Zanini, M., Lopes, R. P., & Bauer, M. E. (2012) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462012000100013 · Cited by 91
Interleukin-10: A Key Cytokine in Depression?
Roque, S., Correia-Neves, M., Mesquita, A. R., Palha, J. A., & Sousa, N. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/187894 · Cited by 89
Modulation of microglial activation by antidepressants
Mariani, N., Everson, J., Pariante, C. M., & Borsini, A. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069110 · Cited by 89
Cattaneo, A., Cattane, N., Malpighi, C., Czamara, D., Suarez, A., Mariani, N., Kajantie, E., Luoni, A., Eriksson, J. G., Lahti, J., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-017-0002-4 · Cited by 86
Karlsson, L., Nousiainen, N., Scheinin, N. M., Maksimow, M., Salmi, M., Lehto, S. M., Tolvanen, M., Lukkarinen, H., & Karlsson, H. (2017) · Archives of Women's Mental Health · doi:10.1007/s00737-016-0672-y · Cited by 85
Altered Serum Levels of TNF-α, IL-6, and IL-18 in Depressive Disorder Patients
Fan, N., Luo, Y., Ou, Y., & He, H. (2017) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2588 · Cited by 85
Ivanovska, M., Abdi, Z., Murdjeva, M., Macedo, D., Maes, A., & Maes, M. (2020) · Pharmaceuticals · doi:10.3390/ph13090230 · Cited by 83
Quinones, M. P., Ahuja, S. K., Melby, P. C., Pate, L., Reddick, R. L., & Ahuja, S. S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.507 · Cited by 81
Defining the Role of Anti- and Pro-inflammatory Outcomes of Interleukin-6 in Mental Health
García‐Juárez, M., & Camacho‐Morales, A. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.03.020 · Cited by 79
Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain
Donninelli, G., Saraf‐Sinik, I., Mazziotti, V., Capone, A., Grasso, M. G., Battistini, L., Reynolds, R., Magliozzi, R., & Volpe, E. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01770-z · Cited by 78
Tryptophan Metabolism and Immunogenetics in Major Depression: A Role for Interferon-γ Gene
Myint, A. M., Bondy, B., Baghai, T. C., Eser, D., Nothdurfter, C., Schüle, C., Zill, P., Müller, N., Rupprecht, R., & Schwarz, M. J. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.04.003 · Cited by 74
Function and proteolytic generation of the soluble interleukin-6 receptor in health and disease
Schumertl, T., Lokau, J., Rose‐John, S., & Garbers, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119143 · Cited by 73 · cited 1×
“It is the only IL-6 receptor type in astrocytes and neurons [85,86].”
BackgroundProssin, A. R., Koch, A. E., Campbell, P. L., McInnis, M. G., Zalcman, S. S., & Zubieta, J.-K. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.10.014 · Cited by 72
Walsh, E., Eisenlohr-Moul, T., & Baer, R. (2016) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000122 · Cited by 72
The Role of Anxious Distress in Immune Dysregulation in Patients with Major Depressive Disorder
Gaspersz, R., Lamers, F., Wittenberg, G., Beekman, A. T. F., van Hemert, A. M., Schoevers, R. A., & Penninx, B. W. J. H. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0016-3 · Cited by 71
Quarta, A., Berneman, Z. N., & Ponsaerts, P. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.023 · Cited by 71
TGF-β/Smad Signalling in Neurogenesis: Implications for Neuropsychiatric Diseases
Hiew, L.-F., Poon, C.-H., You, H.-Z., & Lim, L.-W. (2021) · Cells · doi:10.3390/cells10061382 · Cited by 71
Altered Chemokine Levels in the Cerebrospinal Fluid and Plasma of Suicide Attempters
Janelidze, S., Ventorp, F., Erhardt, S., Hansson, O., Minthon, L., Flax, J., Samuelsson, M., Traskman-Bendz, L., & Brundin, L. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.010 · Cited by 69
Pokryszko‐Dragan, A., Frydecka, I., Kosmaczewska, A., Ciszak, L., Bilińska, M. M., Gruszka, E., Podemski, R., & Frydecka, D. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.02.048 · Cited by 68
Interleukin-6 and Interleukin-10 in Mood Disorders: A Population-Based Study
Wiener, C. D., Moreira, F. P., Portela, L. V., Strogulski, N. R., Lara, D. R., da Silva, R. A., Souza, L. D. D. M., Jansen, K., & Oses, J. P. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.01.100 · Cited by 68
Plasma Interleukin-18 Levels in Patients with Psychiatric Disorders
Kokai, M., Kashiwamura, S.-I., Okamura, H., Ohara, K., & Morita, Y. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200203001-00011 · Cited by 67
Interleukin-1 β-Targeted Treatment Strategies in Inflammatory Depression: Toward Personalized Care
Ellul, P., Boyer, L., Groc, L., Leboyer, M., & Fond, G. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12656 · Cited by 65
Huang, C., Zhang, F., Li, P., & Song, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213856 · Cited by 65
Schmid, A. W., Lynch, M. A., & Herron, C. E. (2009) · Hippocampus · doi:10.1002/hipo.20542 · Cited by 64 · cited 1×
“IL-1RA modulated synaptic plasticity in a rat AD model, where acute beta-amyloid mediated potentiation impairment was possibly caused by inflammatory response and release of IL-1β [53].”
BackgroundElomaa, A.-P., Niskanen, L., Herzig, K.-H., Viinamäki, H., Hintikka, J., Koivumaa-Honkanen, H., Honkalampi, K., Valkonen-Korhonen, M., Harvima, I. T., & Lehto, S. M. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-2 · Cited by 62 · cited 1×
“It is involved in the activation, proliferation, and differentiation of eosinophils and is best known for its involvement in the pathophysiology of autoimmune disorders such as asthma and Graves’ disease [73,74].”
Higher Baseline Interleukin-1β and TNF-α Hamper Antidepressant Response in Major Depressive Disorder
Benedetti, F., Poletti, S., Vai, B., Mazza, M. G., Lorenzi, C., Brioschi, S., Aggio, V., Branchi, I., Colombo, C., Furlan, R., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.009 · Cited by 62
A Study of TNF-α, TGF-β, IL-10, IL-6, and IFN-γ Gene Polymorphisms in Patients with Depression
Mihailova, S., Ivanova-Genova, E., Lukanov, T., Stoyanova, V., Milanova, V., & Naumova, E. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.03.005 · Cited by 61
Production of interleukin-5 by mouse astrocytes and microglia in culture
Sawada, M., Suzumura, A., Itoh, Y., & Marunouchi, T. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90701-l · Cited by 60
Is seasonality of suicides stronger in victims with hospital-treated atopic disorders?
Timonen, M., Viilo, K. M., Hakko, H. H., Särkioja, T., Meyer‐Rochow, V. B., Väisänen, E., & Räsänen, P. K. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.02.005 · Cited by 60
Alvarez-Mon, M. A., Gómez-Lahoz, A. M., Orozco, A., Lahera, G., Diaz, D., Ortega, M. A., Albillos, A., Quintero, J., Aubá, E., Monserrat, J., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030220 · Cited by 57
Increased Soluble TNF Receptor 2 in Antidepressant-Free Patients with Late-Life Depression
Diniz, B. S., Teixeira, A. L., Talib, L. L., Mendonça, V. A., Gattaz, W. F., & Forlenza, O. V. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.02.008 · Cited by 54
Ovaskainen, Y., Koponen, H., Jokelainen, J., Keinänen-Kiukaanniemi, S., Kumpusalo, E., & Vanhala, M. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2007.12.004 · Cited by 53 · cited 1×
“studied IL-1β in males and concluded that decreased levels of this cytokine and elevated levels of the interleukin-1 receptor antagonist (IL-1RA) were more frequent in depressed subjects [47].”
BackgroundBiomarkers Common for Inflammatory Periodontal Disease and Depression: A Systematic Review
Neupane, S. P., Virtej, A., Myhren, L. E., & Bull, V. H. (2022) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2022.100450 · Cited by 52
Is there a link between TNF gene expression and cognitive deficits in depression?
Bobińska, K., Gałecka, E., Szemraj, J., Gałecki, P., & Talarowska, M. (1970) · Acta Biochimica Polonica · doi:10.18388/abp.2016_1276 · Cited by 50
Interleukin-10 Level Is Associated with Post-Stroke Depression in Acute Ischaemic Stroke Patients
Chi, C.-H., Huang, Y.-Y., Ye, S.-Z., Shao, M.-M., Jiang, M.-X., Yang, M.-Y., Wu, Q., Shao, B., & Li, X.-M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.06.037 · Cited by 50
Kruse, J. L., Vasavada, M. M., Olmstead, R., Hellemann, G., Wade, B., Breen, E. C., Brooks, J. O., Congdon, E., Espinoza, R., Narr, K. L., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01268-z · Cited by 48 · cited 1×
“Female rats with lower IL-8 levels are more susceptible to medication and electroconvulsive therapy (ECT) [92,93].”
BackgroundInvolvement of fractalkine and macrophage inflammatory protein‐1 alpha in moderate‐severe depression
Merendino, R. A., Di Pasquale, G., De Luca, F., Di Pasquale, L., Ferlazzo, E., Martino, G., Palumbo, M. C., Morabito, F., & Gangemi, S. (2004) · Mediators of Inflammation · doi:10.1080/09511920410001713484 · Cited by 47
Interferon-gamma (+874) T/A genotypes and risk of IFN-alpha-induced depression
Oxenkrug, G., Perianayagam, M., Mikolich, D., Requintina, P., Shick, L., Ruthazer, R., Zucker, D., & Summergrad, P. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0525-1 · Cited by 47
Targeting the CCL2-CCR2 Axis in Depressive Disorders
Curzytek, K., & Leśkiewicz, M. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00280-w · Cited by 47
Kruse, J. L., Olmstead, R., Hellemann, G., Wade, B., Jiang, J., Vasavada, M. M., Brooks III, J. O., Congdon, E., Espinoza, R., Narr, K. L., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.05.069 · Cited by 46
Serum Interferon-Gamma Level Is Associated with Drug-Naïve Major Depressive Disorder
Daria, S., Proma, M. A., Shahriar, M., Islam, S. M. A., Bhuiyan, M. A., & Islam, M. R. (2020) · SAGE Open Medicine · doi:10.1177/2050312120974169 · Cited by 46
Mitogenic effects of interleukin-5 on microglia
Ringheim, G. E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12153-6 · Cited by 45
Neuroendocrine and cytokines-induced responses to minutes, hours, and days of mental stress.
Matalka, K. Z. (2003) · PubMed · Cited by 45
Interleukin-4 Is a Participant in the Regulation of Depressive-like Behavior
Wachholz, S., Knorr, A., Mengert, L., Plümper, J., Sommer, R., Juckel, G., & Friebe, A. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.03.020 · Cited by 45 · cited 2×
“In a later animal model, rodents treated with IFN-α showed more depressive behaviors in the forced swim test, tail suspension test, and active avoidance task when their IL-4 microglial reactivity was reduced [70,71].”
BackgroundMethodIL-10 Is Associated with Increased Mu-Opioid Receptor Levels in Major Depressive Disorder
Al-Fadhel, S. Z., Al-Hakeim, H. K., Al-Dujaili, A. H., & Maes, M. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.10.001 · Cited by 44
Daytime melatonin levels in saliva are associated with inflammatory markers and anxiety disorders
Sundberg, I., Rasmusson, A. J., Ramklint, M., Just, D., Ekselius, L., & Cunningham, J. L. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104514 · Cited by 43
Porterfield, V. M., Gabella, K. M., Simmons, M. A., & Johnson, J. D. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.08.001 · Cited by 42 · cited 1×
“, where repeated stressor exposure in rats enhanced the production of IL-1β via the norepinephrine beta-adrenergic pathway [50].”
BackgroundSpreading Depression Transiently Disrupts Myelin via Interferon-Gamma Signaling
Pusic, A. D., Mitchell, H. M., Kunkler, P. E., Klauer, N., & Kraig, R. P. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2014.12.001 · Cited by 42
Increased IL-8 Concentrations in the Cerebrospinal Fluid of Patients with Unipolar Depression
Kuzior, H., Fiebich, B. L., Yousif, N. M., Saliba, S. W., Ziegler, C., Nickel, K., Maier, S. J., Süß, P., Runge, K., Matysik, M., et al. (2020) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2020.152196 · Cited by 41 · cited 1×
“in patients suffering from unipolar depression [96].”
Chemokine profile in women with moderate to severe anxiety and depression during pregnancy
Camacho-Arroyo, I., Flores-Ramos, M., Mancilla-Herrera, I., Cruz, F. M. C., Hernández-Ruiz, J., Diaz, G. P., Labonne, B. F., del Pilar Meza-Rodríguez, M., & Gelman, P. L. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04225-2 · Cited by 41
Ho, P.-S., Yen, C.-H., Chen, C.-Y., Huang, S.-Y., & Liang, C.-S. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2016.12.014 · Cited by 39
Wang, P., Feng, Y.-B., Wang, L., Li, Y., Fan, C., Song, Q., & Yu, S. Y. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.08.002 · Cited by 38 · cited 1×
“At the same time, overexpression of IL-6 led to a reduction in these behaviors [83,84].”
BackgroundThe Cytokine IL-17A as a Marker of Treatment Resistance in Major Depressive Disorder?
Nothdurfter, C., Milenkovic, V. M., Sarubin, N., Hilbert, S., Manook, A., Weigl, J., Almeqbaali, K., Wetzel, C. H., Rupprecht, R., & Baghai, T. C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14636 · Cited by 38
Li, J., Leschka, S., Rutschow, S., Schwimmbeck, P. L., Husmann, L., Noutsias, M., Westermann, D., Poller, W. C., Zeichhardt, H., Klingel, K., et al. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.024 · Cited by 37
Sex Differences in the Regulation of Brain IL-1β in Response to Chronic Stress
Barnard, D. F., Gabella, K. M., Kulp, A. C., Parker, A. D., Dugan, P. B., & Johnson, J. D. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.01.026 · Cited by 35 · cited 1×
“reported only male rats to be affected by the beta-adrenergic pathway, while females remained unaffected [51].”
BackgroundCerebrospinal Fluid Levels of Interleukin-8 in Delirium, Dementia, and Cognitively Healthy Patients
Sajjad, M. U., Blennow, K., Knapskog, A. B., Idland, A.-V., Chaudhry, F. A., Wyller, T. B., Zetterberg, H., & Watne, L. O. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190941 · Cited by 34 · cited 15×
“In that case, we can say that low IL-8 levels and susceptibility to treatment do not negate current depression in individuals with higher levels, as there is a possibility of elevated levels in the initial phases.”
InfluentialMagalhaes, P. V. S., Jansen, K., Stertz, L., Ferrari, P., Pinheiro, R. T., da Silva, R. A., & Kapczinski, F. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.10.007 · Cited by 33
Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
Myung, W., Lim, S.-W., Woo, H. I., Park, J. H., Shim, S., Lee, S.-Y., & Kim, D. K. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.6.644 · Cited by 33
Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine
Lombardo, S., Mazzon, E., Basile, M., Cavalli, E., Bramanti, P., Nania, R., Fagone, P., Nicoletti, F., & Petralia, M. (2019) · Brain Sciences · doi:10.3390/brainsci9070172 · Cited by 33 · cited 1×
“Receptor upregulation has been found in patients suffering from migraine with aura symptoms, believed to be associated with cortical spreading depression [55].”
BackgroundMin, Z., Li, Y., & Ying, H. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24559 · Cited by 33
Polacchini, A., Girardi, D., Falco, A., Zanotta, N., Comar, M., De Carlo, N. A., & Tongiorgi, E. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.02.002 · Cited by 30
Kruse, J. L., Olmstead, R., Hellemann, G. S., Breen, E. C., Tye, S. J., Brooks, J. O., Wade, B., Congdon, E. L., Espinoza, R. T., Narr, K. L., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.06.009 · Cited by 30 · cited 1×
“Inconsistencies start with sex differences in rats, where the IL-8 effect on disease severity was associated only with females [91].”
BackgroundImproving Cognition with Nutraceuticals Targeting TGF-β1 Signaling
Grasso, M., Caruso, G., Godos, J., Bonaccorso, A., Carbone, C., Castellano, S., Currenti, W., Grosso, G., Musumeci, T., & Caraci, F. (2021) · Antioxidants · doi:10.3390/antiox10071075 · Cited by 30
Roomruangwong, C., Sirivichayakul, S., Carvalho, A. F., & Maes, M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.033 · Cited by 29
TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer’s Disease
Pillai, J. A., Bebek, G., Khrestian, M., Bena, J., Bergmann, C. C., Bush, W. S., Leverenz, J. B., & Bekris, L. M. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.638922 · Cited by 29
Monocyte Chemoattractant Protein-1 Levels Are Associated with Major Depressive Disorder
Proma, M. A., Daria, S., Nahar, Z., Ashraful Islam, S. M., Bhuiyan, M. A., & Islam, M. R. (2022) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2021-0132 · Cited by 29
The clock‐controlled chemokine contributes to neuroinflammation‐induced depression
Chen, X., Hu, Q., Zhang, K., Teng, H., Li, M., Li, D., Wang, J., Du, Q., & Zhao, M. (2020) · The FASEB Journal · doi:10.1096/fj.201900581rrr · Cited by 28
Increased IL-3 Serum Levels in Chronic Patients with Schizophrenia: Associated with Psychopathology
Xiu, M. H., Lin, C. G., Tian, L., Tan, Y. L., Chen, J., Chen, S., Tan, S. P., Wang, Z. R., Yang, F. D., Chen, D. C., et al. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.07.029 · Cited by 27 · cited 1×
“Moreover, IL-3 levels were positively correlated with depressive subscores [63].”
BackgroundSchmidt, F. M., Koch, J., Nowak, C., Holdt, L. M., Teupser, D., Hegerl, U., & Himmerich, H. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.09.010 · Cited by 27
Mandolesi, G., Bullitta, S., Fresegna, D., Gentile, A., Vito, F. D., Dolcetti, E., Rizzo, F. R., Strimpakos, G., Centonze, D., & Musella, A. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.019 · Cited by 26
Euteneuer, F., Schwarz, M. J., Dannehl, K., Hartung, A., Westermann, S., & Rief, W. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.007 · Cited by 25 · cited 2×
“Serum levels of sIL-2R are increased in MDD and correlate with somatoform symptoms and somatic anxiety in depression but not with the overall severity of the disease [56,59].”
BackgroundTumor Necrosis Factor and the Tenacious α
Grimstad, Ø. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.4322 · Cited by 25
Ivanovska, M., Abdi, Z., Murdjeva, M., Macêdo, D. S., Maes, A., & Maes, M. H. J. (2020) · Preprints.org · doi:10.20944/preprints202001.0370.v1 · Cited by 24
Chou, Y.-H., Hsieh, W.-C., Chen, L.-C., Lirng, J.-F., & Wang, S.-J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.10.056 · Cited by 23 · cited 1×
“In a later animal model, rodents treated with IFN-α showed more depressive behaviors in the forced swim test, tail suspension test, and active avoidance task when their IL-4 microglial reactivity was reduced [70,71].”
MethodQiu, A., Zhang, H., Wang, C., Chong, Y.-S., Shek, L. P., Gluckman, P. D., Meaney, M. J., Fortier, M. V., & Wu, Y. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01292-z · Cited by 23
El-Tantawy, A., el-Sayed, A. E., Kora, B. A., & Amin, R. T. (2008) · PubMed · Cited by 22
Li, Y., Xie, Y., Xu, Y., Xian, X., Wang, R., Cai, L., Li, G., & Li, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.03.003 · Cited by 22 · cited 2×
“After the period of acute stress, the IL-6 white matter network differences were shown to be strongly associated with the interindividual variation in susceptibility to depressive disorder in healthy individuals with SLEs [80].”
BackgroundManfro, P. H., Anselmi, L., Barros, F., Gonçalves, H., Murray, J., Oliveira, I. O., Tovo-Rodrigues, L., Wehrmeister, F. C., Menezes, A. M. B., Mondelli, V., et al. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.03.065 · Cited by 22 · cited 1×
“disturbances, low mood, and feelings of worthlessness has been confirmed [82].”
BackgroundKruse, J. L., Boyle, C. C., Olmstead, R., Breen, E. C., Tye, S. J., Eisenberger, N. I., & Irwin, M. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-16364-3 · Cited by 22 · cited 1×
“Whole blood sample examination in a randomized study reported the possibility of IL-8 effect on depression to be rather mitigative than enhancing, where patients with higher levels of IL-8 are less likely to suffer from inflammation-associated depression [97].”
BackgroundUshiroyama, T., Ikeda, A., & Ueki, M. (2002) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(02)00189-3 · Cited by 20 · cited 1×
“In addition to increased IL-6 levels, sIL-R6 levels were reported in depressed patients, with elevated levels of both persisting even after the start of antidepressant treatment [87,88].”
BackgroundClinical Phenotype of Depression Affects Interleukin-6 Synthesis
Zadka, Ł., Dzięgiel, P., Kulus, M., & Olajossy, M. (2017) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0074 · Cited by 20
Increased Systemic Microbial Translocation Is Associated with Depression during Early Pregnancy
Zhou, Z., Guille, C., Ogunrinde, E., Liu, R., Luo, Z., Powell, A., & Jiang, W. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.11.009 · Cited by 20
Transforming Growth Factor Beta (TGF-β) in Adolescent Chronic Fatigue Syndrome
Wyller, V. B., Nguyen, C. B., Ludviksen, J. A., & Mollnes, T. E. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1350-1 · Cited by 20
Circulating Cytokines as Predictors of Depression in Patients with Breast Cancer
Ho, H.-Y., Chin-Hung Chen, V., Tzang, B.-S., Hsieh, C.-C., Wang, W.-K., Weng, Y.-P., Hsu, Y.-T., Hsaio, H.-P., Weng, J.-C., & Chen, Y.-L. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.037 · Cited by 20 · cited 1×
“Recent research on circulating cytokine levels in breast cancer patients even found IL-5 levels decreased in the depressed group [35,77].”
BackgroundAssessment of a Multi-Assay Biological Diagnostic Test for Mood Disorders in a Japanese Population
Yamamori, H., Ishima, T., Yasuda, Y., Fujimoto, M., Kudo, N., Ohi, K., Hashimoto, K., Takeda, M., & Hashimoto, R. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.019 · Cited by 19
VARSHNEY, P., PARVEEN, R., KHAN, M. A., KOHLI, S., & AGARWAL, N. B. (2020) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20190177 · Cited by 19
Interleukin 13 (IL‐13) alters hypoxia‐associated genes and upregulates CD73
Khalil, S. M., Bernstein, I. A., Kulaga, H. M., Gour, N., Rowan, N. R., Lajoie, S., & Lane, A. P. (2020) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22630 · Cited by 17
Ferreira, A. M., Leal, B., Ferreira, I., Brás, S., Moreira, I., Samões, R., Sousa, A. P., Santos, E., Silva, B., Costa, P. P., et al. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102982 · Cited by 17 · cited 1×
“reported a possible association of SNP in the IL1B gene (rs16944; 511 C > T) with higher susceptibility to depression in patients with multiple sclerosis (MS) [46].”
BackgroundAltered Levels of Salivary Cytokines in Patients with Major Depressive Disorder
Yui, S., Sasayama, D., Yamaguchi, M., & Washizuka, S. (2022) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2022.107390 · Cited by 16 · cited 1×
“However, it is not yet thoroughly researched to what degree the changes in saliva correlate with changes in blood samples [33].”
BackgroundMohite, S., Cordeiro, T., Tannous, J., Mwangi, B., Selvaraj, S., Soares, J. C., Sanches, M., & Teixeira, A. L. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.062 · Cited by 15
IL-1 Receptor-Antagonist (IL-1Ra) Knockout Mice Show Anxiety-like Behavior by Aging
Wakabayashi, C., Numakawa, T., Odaka, H., Ooshima, Y., Kiyama, Y., Manabe, T., Kunugi, H., & Iwakura, Y. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.05.019 · Cited by 14
Research works printed but not linked: 9
- (2022, December 18). IL3 Interleukin 3 [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/3562.
- (2022, November 30). IL12A Interleukin 12A [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/3592.
- (2022, November 30). IL12B Interleukin 12B [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/3593.
- (2022, November 30). IL13 Interleukin 13 [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/3596.
- (2022, December 13). IL17A Interleukin 17A [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/3605.
- (2022, November 30). IL18 Interleukin 18 [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/3606.
- (2022, December 13). CCL2 C-C Motif Chemokine Ligand 2 [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/6347.
- (2022, November 30). TNF Tumor Necrosis Factor [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/7124.
- (2022, November 30). TNFRSF1B TNF Receptor Superfamily Member 1B [Homo Sapiens (Human)]-Gene-NCBI, Available online: https://www.ncbi.nlm.nih.gov/gene/7133.
Cited by
Yin, Y., Ju, T., Zeng, D., Duan, F., Zhu, Y., Liu, J., Li, Y., & Lu, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107322 · Cited by 178
Cardiovascular disease and depression: a narrative review
Li, X., Zhou, J., Wang, M., Yang, C., & Sun, G. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1274595 · Cited by 129
Pathogenesis and treatment of depression: Role of diet in prevention and therapy
Mrozek, W., Socha, J., Sidorowicz, K., Skrok, A., Syrytczyk, A., Piątkowska‐Chmiel, I., & Herbet, M. (2023) · Nutrition · doi:10.1016/j.nut.2023.112143 · Cited by 78
The characteristics of anhedonia in depression: a review from a clinically oriented perspective
Wu, C., Mu, Q., Gao, W., & Lu, S. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03310-w · Cited by 85
Inflammatory biomarkers in depression: scoping review
Paganin, W., & Signorini, S. (2024) · BJPsych Open · doi:10.1192/bjo.2024.787 · Cited by 57
Metadata
- Authors
- Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M.
- Affiliations
- Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, Sasinkova 4, 811 08 Bratislava, Slovakia
- Comenius University Bratislava (SK)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-12-29
- Volume
- 24
- Issue
- 1
- Pages
- 578
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9820159
- OpenAlex
- W4313361124
- Semantic Scholar
- ff8ea139489ad0c55b6a066d65875eb9feda6c69
- Cited by
- 299
- References
- 218
- Citations by year
- 2026: 71 · 2025: 117 · 2024: 82 · 2023: 29
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- depression, biomarkers, cytokines, inflammation, major depressive disorder, oxidative stress, neuropeptides, stress response, animal models of depression, depression diagnosis, depression pathogenesis
- MeSH terms
- Animals, Depression, Depressive Disorder, Major, Major Depressive Disorder, Inflammation, Quality of Life, Biomarkers, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
